Abstract

Fibrinolytic proteases are a promising alternative in the pharmaceutical industry, they are used in the treatment of cardiovascular diseases, especially thrombosis. Microorganisms are the most interesting source of fibrinolytic proteases. The aim of this study was the production of fibrinolytic protease from Streptomyces parvulus DPUA 1573, the recovery of the protease by aqueous two-phase system and partial biochemical characterization of the enzyme. The aqueous two-phase system was performed according to a 24-full factorial design using polyethylene glycol molar mass, polyethylene glycol concentration, citrate concentration and pH as independent variables. It was analyzed the effect of different ions, surfactants, inhibitors, pH and temperature on enzyme activity. The best conditions for purifying the enzyme were 17.5% polyethylene glycol 8,000, 15% Phosphate and pH 8.0, it was obtained a partition coefficient of 7.33, a yield of 57.49% and a purification factor of 2.10-fold. There was an increase in enzyme activity in the presence of Fe2+ and a decrease in the presence of $\beta$-Mercaptoethanol, phenylmethylsulfonyl fluoride and Iodoacetic acid. The optimum pH was 7.0 and the optimum temperature was 40 ºC. The purified protease exhibited a molecular mass of 41 kDa. The fibrinolytic protease from Streptomyces parvulus proved to be a viable option for the development of a possible drug with fibrinolytic action.

Highlights

  • Thrombosis is a cardiovascular disease with the highest morbidity and mortality worldwide

  • The medium composed of passion fruit flour produced the greatest amount of fibrinolytic protease

  • 6.23 ± 0.19 8.71 ± 0.32 0 a Protease activity; b Fibrinolytic activity described by Wang et al (2011); c Fibrinolytic activity described by Astrup & Mullertz (1952)

Read more

Summary

Introduction

Thrombosis is a cardiovascular disease with the highest morbidity and mortality worldwide. It is caused by unbalanced formation and accumulation of blood clots that block the normal flow blood (Preston et al 2019). These clots are formed from conversion of fibrinogen to fibrin due to the proteolytic action of thrombin (Kattula et al 2017). PURIFICATION AND CHARACTERIZATION OF PROTEASE of thrombotic diseases. In this context, fibrinolytic enzymes are an alternative for the treatment of these diseases (Bray et al 2020, Jiang et al 2020)

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call